This report, Kalorama’s Cell and Gene Deals and Market Analysis, tracks the dealmaking and market opportunity for cell and gene therapy companies.  A lot of attention is being given to the areas related to cell and gene therapy (CGT) recently. Kalorama’s latest report finds that the volume of deals between companies and other funding entities […]

Your Resource for Business Planning in the Clinical Laboratory Market What’s the size of the service market for clinical testing?  What type of tests are selling?  Where is this market going next five years?  Which companies will earn those revenues?  Where is growth coming from? How will LDT regulation affect the market?  What are companies planning […]

Covid-19 testing has been at the forefront in battling the pandemic. However, as the pandemic recedes and becomes more endemic, what will happen to the ever-changing COVID-19 testing market? Kalorama Information answers this question and more in COVID-19 Testing Markets, 2023. The pandemic has been a learning curve for all parties to invest in diagnostic […]

The point-of-care diagnostics market has long been the opportunity market within IVD.  Kalorama publishes a full-scope market research study annually on point of care (POC) devices that can test near the patient for maximum benefit to healthcare encounters.  While tests run on lab-based analyzers, remain the bedrock of IVD revenues, point of care has always […]

SKU 23-708: There is a nearly $10 billion-dollar market for hematology and coagulation IVD testing.  Increasingly growth is driven by new technologies, the aging population, and the demand for decentralized testing.   This report provides: Market sizing for Hematology IVD and Coagulation IVD Markets for Decentralized and Lab-based Segments. Forecasts to 2027 Market Share Country Markets […]

The Market for Single Cell Analysis in Genomics: Next-Generation Sequencing and Other Technology, 2023-2027  focuses on the market for single cell genomics products. Analyzed are the hardware, service of the hardware, software, and consumables included for the sequencing step and other types of downstream analysis. Single cell RNA-seq enables new types of analyses, for instance: […]

It's like buying 10 reports in one volume.  This volume provides readers with IVD market sizing and forecasting in every area of the industry.  Published in 2022, but updated with an addendum chapter in March 2023, the 15^th edition of Kalorama’s Worldwide Market for In Vitro Diagnostic Tests is a 1500+ page report is based on vendor reporting, interviews, vendor activities, and more on a global scale.  In Vitro Diagnostics sales exceeded 124 billion in 2022.   It is projected to grow over the next five years, this resource describes all of the ways that will happen, which areas are hot and cold, and which companies stand to benefit.

Diagnostic testing continues to be a valuable resource to help physicians arrive at a diagnosis. Additionally, it has gone from helping the physician to diagnose illness to providing the physician with invaluable information on treatments such as precision medicine. Now, in the aftermath of the COVID-19 pandemic, new products, changes in global health spending, regulatory […]

The IVD market is over 120 billion dollars, and it is a global market.  Less than half of revenue is earned in the United States.  For successful business planning, an assessment of regional and country IVD markets are needed.   Kalorama information’s IVD Market Atlas is designed based on customer feedback to provide international markets and […]

This report is an essential tool for understanding the size and growth opportunity in molecular POC.  Molecular point of care (mPOC) has gone from novel trend to significant contributor to the market.  The instruments sold by Abbott, BioMérieux, Cepheid and increasingly, a host of other companies, are a significant contributor to the IVD POC market.  […]